Understanding Piezo1 in this framework is crucial for developing novel therapies targeting tumour immune evasion, positioning Piezo1 as a tunable signalling hub rather than a simple mechanosensor and guiding the design of more precise immunomodulatory strategies. Here, PIEZO1 is linked to neoplasm.